ArticleBreast cancer research : BCR2025

Molecular convergence of luminal androgen receptor and molecular apocrine defines a distinct entity in ER-negative breast tumors.

Adrien Borgel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.